Align Technology, US0162551016

Align Technology sets October 28 results. Align Technology stock is 27.49 percent below high

Published on 10/02/2026 at 13:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 4.30 percent to USD 1.06 billion. Align Technology stock costs EUR 129.73 on October 2, 2026 versus EUR 129.30, plus 0.33 percent.

Architekturrender moderner Medtech-Campus in der Wüste Arizonas
Align Technology Inc. Architekturrender moderner Medizintechnik-Campus in Arizona Firmensitz digitale Kieferorthopädie NASDAQ US0162551016, Illustration mit AI erstellt.

Align Technology (ISIN US0162551016) set October 28, 2026 as the date for its third-quarter 2026 results, according to Yahoo Finance on October 1, 2026. The Nasdaq price context was USD 145.34 on October 1, 2026, or 27.49 percent below the USD 200.44 52-week high. Lang & Schwarz quoted Align Technology at EUR 129.73 on October 2, 2026 at 1:10 p.m. CEST, plus 0.33 percent versus the EUR 129.30 prior close.

October 28 anchors the calendar

The reporting date gives investors the next fixed checkpoint for Align Technology's 2026 outlook. Yahoo Finance said the release is scheduled after the market close, with the conference call starting at 4:30 p.m. ET.

The company designs Invisalign clear aligners, iTero intraoral scanners and exocad computer-aided design software. Investing.com identifies Align Technology as a Nasdaq-listed company under ticker ALGN and ISIN US0162551016.

Revenue growth meets margin pressure

In the second quarter of 2026, revenue increased 4.30 percent year over year to USD 1.06 billion, while non-GAAP earnings per share rose 6.00 percent to USD 2.64, according to Zacks.

The quarter contained a clear split between the main aligner business and equipment. Clear aligner revenue rose 8.20 percent year over year to USD 870.9 million, while Imaging Systems and CAD/CAM Services revenue fell 10.80 percent to USD 185.3 million, Zacks reported.

Clear aligners outpace scanners

Operationally, 89,200 doctors submitted Invisalign cases in the second quarter of 2026, and doctor utilization increased 3.80 percent year over year. The scanner business still placed more units, but lower-priced products, rentals and leasing programs weighed on revenue, according to Zacks.

That mix matters for the October results. The company entered the third quarter with a USD 1.00 billion to USD 1.02 billion revenue outlook, while the Zacks consensus stood at USD 1.01 billion, a direct comparison that leaves execution and product mix as the key variables.

Stock remains below its yearly high

Align Technology's USD 10.4 billion market capitalization and USD 124.91 to USD 200.44 52-week range frame the Nasdaq valuation as of October 1, 2026. The Lang & Schwarz euro quote moved only 0.33 percent above its prior close, keeping the October 28 report as the next dated reference point rather than a large same-day price move.

At Lang & Schwarz, Align Technology was trading at EUR 129.73 on October 2, 2026 at 1:10 p.m. CEST, compared with the EUR 129.30 prior close from October 1, 2026. The further course of trading is shown by the continuously updated real-time quote of Align Technology stock.

Align Technology stock facts

  • Company: Align Technology, Inc.
  • ISIN: US0162551016
  • Ticker: ALGN
  • Primary exchange: Nasdaq
  • Price Lang & Schwarz as of October 2, 2026, 1:10 p.m. CEST: EUR 129.73
  • Change versus prior close: plus 0.33 percent
  • Prior close Lang & Schwarz October 1, 2026: EUR 129.30
  • Market capitalization: USD 10.4 billion as of October 1, 2026
  • 52-week range: USD 124.91-200.44 as of October 1, 2026
  • Sector / Industry: Healthcare / Medical Devices
  • Next earnings date: October 28, 2026

More news and analyses on Align Technology stock

Disclaimer...

en | US0162551016 | ALIGN TECHNOLOGY | boerse | 70215091 | bgmi